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Improved vanillin production in baker’s yeast
through in silico design
Ana Rita Brochado1,4, Claudia Matos1, Birger L Møller2, Jørgen Hansen3, Uffe H Mortensen1, Kiran Raosaheb Patil4*
Abstract
Background: Vanillin is one of the most widely used flavouring agents, originally obtained from cured seed pods
of the vanilla orchid Vanilla planifolia. Currently vanillin is mostly produced via chemical synthesis. A de novo
synthetic pathway for heterologous vanillin production from glucose has recently been implemented in baker’s
yeast, Saccharamyces cerevisiae. In this study we aimed at engineering this vanillin cell factory towards improved
productivity and thereby at developing an attractive alternative to chemical synthesis.
Results: Expression of a glycosyltransferase from Arabidopsis thaliana in the vanillin producing S. cerevisiae strain
served to decrease product toxicity. An in silico metabolic engineering strategy of this vanillin glucoside producing
strain was designed using a set of stoichiometric modelling tools applied to the yeast genome-scale metabolic
network. Two targets (PDC1 and GDH1) were selected for experimental verification resulting in four engineered
strains. Three of the mutants showed up to 1.5 fold higher vanillin b-D-glucoside yield in batch mode, while
continuous culture of the Δpdc1 mutant showed a 2-fold productivity improvement. This mutant presented a 5-
fold improvement in free vanillin production compared to the previous work on de novo vanillin biosynthesis in
baker’s yeast.
Conclusion: Use of constraints corresponding to different physiological states was found to greatly influence the
target predictions given minimization of metabolic adjustment (MOMA) as biological objective function. In vivo
verification of the targets, selected based on their predicted metabolic adjustment, successfully led to
overproducing strains. Overall, we propose and demonstrate a framework for in silico design and target selection
for improving microbial cell factories.
Background
Vanillin is a plant secondary metabolite and the main
constituent of natural vanilla - one of the most impor-
tant flavouring agents. The annual market for vanillin
exceeds 16,000 tons, although only 0.25% of this origi-
nates from cured seed pods of the vanilla orchid,
Vanilla planifolia. The remaining demand for vanillin is
fulfilled by chemical synthesis from lignin or fossil
hydrocarbons, in particular guaiacol [1]. Sustainable and
environmental friendly routes have been proposed for
obtaining vanillin through bioconversion of eugenol and
ferulic acid by bacteria or fungi [2-4]. To this end, an
attractive option was recently reported by Hansen et al
(2009), who demonstrated de novo vanillin biosynthesis
from glucose in baker’s and fission yeasts as a major step
towards developing an environmental friendly and eco-
nomically sustainable process [5]. The native metabolic
precursor for this de novo pathway is 3-dehydroshikimate
(3-DHS), an intermediate of the shikimate pathway for
aromatic amino acids biosynthesis. To convert 3-dehry-
droshikimate into vanillin, four genes encoding the
required four enzymatic activities were obtained from dif-
ferent organisms, Podospora pausiceta, Nocardia sp.,
Escherichia coli and Homo sapiens (Figure 1) [5]. Inspired
by the fact that metabolic engineering has been success-
fully applied to improve the yield of e.g. sesquiterpenes
[6], ethanol [7,8], artemisinic acid [9] and succinic acid
[10] production in Saccharomyces cerevisiae, we hypothe-
sized that vanillin production could also be improved by
implementing a metabolic engineering strategy [11]. An
immense collection of systems biology tools, in addition
to well-established technologies for genetic manipulation,
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renders S. cerevisiae a very amenable organism for meta-
bolic engineering [12-14].
The aim of this study was to design and construct an
improved S. cerevisiae vanillin cell factory guided by gen-
ome-scale metabolic modelling. In silico metabolic engi-
neering algorithms were used to identify target reactions
in the metabolic network, knockout of which would lead
to improved vanillin production. A set of knockouts that
maximizes the flux towards a desired metabolite must be
searched for, while the overall flux distribution is deter-
mined by the cellular objective function (e.g. maximiza-
tion of biomass yield). This problem was formulated by
Burgard et al. (2003) as a bi-level optimization algorithm
termed OptKnock [15]. OptKnock can be applied in case
of a linear design objective, such as maximizing flux
towards a desired metabolite [15]. Optimization of non-
linear objective functions, such as productivity, is also of
great interest for a variety of metabolic engineering pro-
blems. OptGene, an extension of OptKnock, allows maxi-
mization of non-linear objective functions, while at the
same time accounting for non-linear constraints on the
metabolic network [16].
The most widely used approach for calculating flux dis-
tribution is flux balance analysis (FBA), where a given
flux (or a linear combination of chosen fluxes) is used as
the objective function [17]. For microorganisms, biomass
maximization is generally accepted as a cellular objective
function when simulating flux distributions [18,19]. Alter-
native fluxes have been proposed as biologically meaning-
ful objective functions, such as maximization of ATP
yield [20]. FBA has been successfully applied to predict
gene essentiality [21,22], end point of adaptive evolution
experiments [23] and optimal metabolic states under
given environmental conditions [19]. However, a mutant
strain that is not subjected to evolutionary pressure
might have a disturbed metabolic network and the princi-
ple of optimality for growth may not be prevailing. To
address this question, the algorithm Minimization Of
Metabolic Adjustments (MOMA) has been suggested by
Segrè et al. (2002), where it is advocated that the cellular
objective for a mutant strain is to minimize its metabolic
distance from the wild type flux distribution [24]. In
MOMA approach, it is crucial to have a physiologically
meaningful wild type flux distribution, as it will strongly
influence the predicted phenotype [24]. Within this
study, the S. cerevisiae genome-scale stoichiometric
model iFF708 [22] was used to identify and select target
reactions by using OptGene [16]. MOMA [24] was used
as the biological objective function with wild type flux
distributions spanning three major modes of yeast meta-
bolic physiology. The model-based metabolic engineering
strategy was tested experimentally by strain construction
and characterization. These research efforts resulted in
three mutant yeast strains with significantly increased
vanillin production.
Results and Discussion
Vanillin b-D-glucoside production in S. cerevisiae
Vanillin is toxic to many living organisms. In case of
S. cerevisiae, growth defect is significant with concentra-
tions as low as 0.5 g/l [5]. Tackling the problem of
vanillin toxicity is therefore an important pre-requisite
for building an economically viable vanillin cell factory.
An elegant solution is glycosylation of vanillin, which is
observed in the natural producer Vanilla planifolia
[25,26]. This strategy was successfully implemented by
Hansen et al. (2002) in Schizosaccharmyces pombe [5].
The glycosylation step implies reduction in the maxi-
mum theoretical yield, from 0.57 mmolVan/molglc to
0.35 mmolVan/molglc. On a mass basis, the maximum
Figure 1 Schematic representation of the de novo VG biosynthetic pathway in S. Cerevisisae (as designed by Hansen et al [5]). Metabolites are
shown in black, enzymes are shown in black and in italic, cofactors and additional precursors are shown in red. Reactions catalyzed by heterologously
introduced enzymes are shown in red. Reactions converting glucose to aromatic amino acids are represented by dashed black arrows. Metabolite
secretion is represented by solid black arrows where relative thickness corresponds to relative extracellular accumulation. 3-DSH stands for 3-
dedhydroshikimate, PAC stands for protocathechuic acid, PAL stands for protocatechuic aldehyde, SAM stands for S-adenosylmethionine. 3DSD stands
for 3-dedhydroshikimate dehydratase, ACAR stands for aryl carboxylic acid reductase, PPTase stands for phosphopantetheine transferase, hsOMT stands
for O-methyltransferase, and UGT stands for UDP-glycosyltransferase. Adapted from Hansen et al. [5].
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achievable yield of 486 mgvan/gglc changes to a relatively
modest 293 mgVan/gglc. Nevertheless, given the toxicity
and low solubility of vanillin, reaching high titers is not
a favourable option. In case of Vanillin b-D-glucoside
(or VG), extracellular concentration up to 25 g/l has
been shown not to affect growth and is thereby more
suitable for commercial production.
In S. pombe, heterologous expression of a gene encod-
ing a plant family 1 glycosyltransferase from Arabidopsis
thaliana (UGT72E2) resulted in 80% conversion of
vanillin to vanillin b-D-glucoside [5]. Within this study,
UGT72E2 was expressed in the vanillin producing S.
cerevisiae strain VAN286, obtained from Hansen et al.
[5]. The resulting strain, VG0, was grown in minimal
medium containing 20 g/l glucose for 90 h. At this
point, the culture was harvested and the extracellular
broth was analysed for the presence of vanillin and VG.
VG had significantly accumulated in the broth (>100
mg/l), while vanillin was barely detectable (<7 mg/l)
indicating efficient conversion of vanillin into VG.
In silico design
Existence of a large number of alternative flux routes
(pathways) in genome-scale metabolic models requires
the use of experimental constraints in order to obtain
physiologically meaningful flux distributions. This is
even more so in the case of MOMA, where predictions
of mutant flux distributions will be highly dependent on
the solution provided for the wild type (or reference)
flux distribution [24]. Thus, the model formulation
should be capable of taking into account the basic meta-
bolic physiological characteristics of the strains under
consideration. In particular, when grown with a fermen-
table carbon source, S. cerevisiae has the ability to grow
in the absence of oxygen, producing ethanol as a major
by-product. In the presence of oxygen, respiration
occurs but if the glucose concentration and/or uptake
rate surpasses a critical threshold value, the metabolism
becomes a combination of respiration and alcoholic fer-
mentation [27,28].
Reference metabolic states
Different metabolic states of S. cerevisiae are character-
ized by different nutrient uptake rates, different metabo-
lite production rates and different biomass yields.
Consequently, it is important to decide which metabolic
state/s should be used to constrain the metabolic model
in order to obtain reliable target predictions for genetic
manipulation towards improved productivity. In addi-
tion, it is to be expected that different constraints (cor-
responding to different metabolic states) may lead to
different suggestions for the metabolic engineering tar-
gets. To address this issue, we used three different sce-
narios for obtaining the reference flux distribution for
MOMA simulations. Reference 1 represented exclusive
respiratory metabolism, characterized by no ethanol for-
mation and low glucose uptake rate. Reference 2 was
simulated for respiro-fermentative metabolism, charac-
terized by high glucose uptake rates, alcoholic fermenta-
tion and active respiration. Since both flux distributions
were obtained by using FBA for maximizing biomass
production, no accumulation of VG or related com-
pounds was predicted. A third FBA simulation was per-
formed to obtain the flux distribution for VG0
(Reference 3). The model was constrained using data
obtained in this study from chemostat cultivations at a
dilution rate of 0.1 h-1. Highly fermentative metabolism
was observed at this dilution rate indicating limited
respiratory capacity of the strain. Together, the three
different reference flux distributions span all relevant
life styles of S. cerevisiae, and may therefore be used to
identify potential targets for genetic manipulations by
using OptGene simulation framework. As steady state
approaches cannot predict changes in substrate uptake
rates, and hence productivity for mutants, Patil et al.
(2005) suggested the use of Biomass Product Coupled
Yield (BPCY) for design objective. BPCY is defined as
multiplication of product yield and biomass flux [16].
Assessment of in silico predictions
Simulations were performed using OptGene [16] for
predicting up to six reaction knockout targets. Improved
VG production was not predicted when using maximiza-
tion of biomass production as biological objective, while
the use of MOMA [24] suggested interesting targets
even after a single reaction deletion. The targets sug-
gested by OptGene were verified for optimality by using
OptKnock [15]. Among a variety of possible target reac-
tions (Figure 2A), biomass and VG yield are generally
related with an inverted trend, so when predicted bio-
mass yield is high, predicted product yield tends to be
modest and vice-versa. Target selection for experimental
validation must strike a good balance between improved
VG production and a reasonable prediction for biomass
yield (Figure 2A). Metabolic adjustment (as defined by
Segrè et al., 2002 [24]) was used as an additional factor
to rank each of the candidate target sets. Briefly, meta-
bolic adjustment of a mutant is defined as the Euclidean
distance between the reference and the mutant flux dis-
tribution vectors. Our hypothesis is that smaller meta-
bolic adjustments are more likely to be achieved in vivo
than large adjustments. This was taken into account by
introducing a new metric for ranking in silico predicted
mutants, viz., the Reward-Risk-Ratio (R3), defined as the
ratio between BPCY (reward) and metabolic adjustment
(risk). The most interesting targets obtained following
ranking of each prediction according to the R3 score are
presented in Figure 2 (B, C and D).
Depending on the reference flux distribution used in
MOMA, different targets were suggested for knockout.
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Some of the targets, for example GDH1, were identified
in more than one physiological growth condition. How-
ever, their positions following the R3 ranking are very
different, demonstrating that the best targets in one
physiological scenario are not necessarily the best tar-
gets in another. The results of the prediction analysis
imply that VG production is favoured at those physiolo-
gical conditions which lead to respiro-fermentative
metabolism as compared to physiological conditions
resulting exclusively in respiratory metabolism. The out-
come of minimal metabolic adjustment is to divert the
ethanol flux towards formation of VG rather than
diverting the flux from biomass constituents. Indeed,
several of the candidates suggested in Figure 2 are pre-
dicted to have lower ethanol formation than the refer-
ence. Likewise, the biomass yield predicted for all the
suggested mutants (with VG0 flux distribution as a
reference) is slightly higher than for the reference, again
at the expense of ethanol formation. Among the targets
depicted in Figure 2, pyruvate seems to embrace a rele-
vant stoichiometric bottleneck since several reactions
from pyruvate metabolism were suggested as targets for
deletion while considering different reference flux distri-
butions. Furthermore, genes related to the metabolism
of ammonium, the pentose phosphate pathway and cen-
tral carbon metabolism in general, were also identified.
Target selection
The targets for in vivo implementation were selected by
giving strong emphasis to the R3 score of different targets
under different simulation conditions, in combination
with a manual evaluation of the suitability of the putative
gene targets based on available data in the literature. The
literature and database search included the possible exis-
tence of iso-enzymes, experimentally observed single gene
deletion phenotypes and the assessment of the importance
of regulatory links to other processes [29]. Based on this
analysis, two gene candidates, PDC1 (Pyruvate decarboxy-
lase) and GDH1 (Glutamate dehydrogenase), were selected
as the candidates for strain construction and characteriza-
tion. The Gdh1 catalyzed reaction was predicted as a
prime target for knockout when using respiratory or
respiro-fermentative metabolism, and in both cases, rela-
tively large metabolic adjustment was predicted. GDH1
encodes an NADPH-dependent glutamate dehydrogenase
involved in ammonium metabolism through glutamate
biosynthesis, which is reported to provide 85% of the cel-
lular nitrogen sources [30]. Ammonium metabolism has
been extensively studied in S. cerevisiae and in particular,
deletion of GDH1 was previously used as a metabolic
engineering strategy for improving ethanol and sesquiter-
penes production [6,8,31]. The engineered strains were
reported to have an increased NADPH pool, a kinetic/
Figure 2 Comparison of targets predicted by OptGene for improved VG productivity. A - Biomass versus VG yield is represented for each
knockout mutant phenotype obtained after OptGene simulation using three different reference flux distributions for MOMA. Experimental yields
observed for VG0 are represented by the red empty triangle and bar. B/C/D - The predicted VG yield (mol/molglc) obtained for each knockout
mutant after OptGene simulation using Reference 1/2/3 is given by the length of the coloured bars. For each reference flux distribution, the R3
score was estimated for each of the mutants was calculated and normalized to the mutant presenting the highest value: MAmut/MAmax*100.
100% represents the mutant with highest R3 score for a given flux distribution. Candidate 80%PDC is not a knockout in silico mutant, rather its
PDC reaction is constrained to 80% of the upper bound.
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thermodynamic feature which was not considered in our
modelling strategy. Therefore, even though the deletion of
this gene was not suggested when the network was con-
strained with experimental results (VG0), we expect the
deletion of this gene to thermodynamically favour the con-
version of PAC to PAL by ACAR.
Pyruvate is a key metabolite in S. cerevisiae metabolism
and the branch point between respiratory and fermenta-
tive metabolism. Pyruvate decarboxylases (PDCs) have a
crucial significance for fermentation, since this decarbox-
ylation reaction converts pyruvate to acetaldehyde, an
intermediate towards ethanol formation [32]. The S. cere-
visiae genome harbours three PDC structural genes
(PDC1, 5 and 6), one regulatory gene (PDC2) and two
other genes with potential contribution towards PDC
activity (PDC3 and 4) [32,33]. Complete suppression of
pyruvate decarboxylase activity (pdc1Δ, pdc5Δ & pdc6Δ)
creates a mutant that is unable to grow on glucose as
sole carbon source [33,34]. By in silico analysis, PDC was
found as a target to increase the formation of VG consid-
ering both respiratory and respiro-fermentative reference
flux distributions for MOMA, but not when VG0 data
was used to constrain the network. Furthermore, com-
plete absence of pyruvate decarboxylase activity under a
highly fermentative mode was predicted to result in zero
growth, as lack of PDC activity would require a very large
metabolic adjustment. This observation, in combination
with the experimental data available in the literature for
the mutant without PDC activity [33,34], raise an inter-
esting question - what would be the effect of only partial
reduction of PDC activity, e.g. by deletion of one of the
structural genes? In order to simulate this situation, PDC
flux was constrained to 80% of the flux observed in the
reference strain. This simulation predicted positive
growth as well as higher VG production in comparison
to other targets such as GDH1 (Figure 2). Of the three
PDC structural genes, PDC1 was selected as a target for
deletion in vivo as there is experimental evidence that its
removal results in ~30% reduction of total pyruvate dec-
arboxylase activity [34].
Strain construction and characterization
Following the selection of the two target genes, two sin-
gle gene deletion mutants, gdh1Δ and pdc1Δ, were con-
structed in the VG0 background resulting in VG1 and
VG2, respectively. To test whether simultaneous dele-
tion of PDC1 and GDH1 would have a positive synergis-
tic effect on VG accumulation, a mutant with both
deletions was obtained (VG3). The strains were initially
characterized in batch cultures in 2L well-controlled
bioreactors, using minimal medium and an initial glu-
cose concentration of 20 g/l (Table 1). The mutant VG2
(pdc1Δ) showed an overall increased fitness compared
to the reference strain as documented by a 43% higher
maximum specific growth rate (μmax, (h
-1) a doubling
time-1) in comparison to VG0. Likewise the yield of bio-
mass on glucose (YS X, gDW/g) is 40% higher than
observed for VG0. On the other hand, the mutant VG1
(gdh1Δ) showed reduced strain fitness, illustrated by
poor μmax and reduced YS X. These adverse effects on
VG1 fitness were partially relieved by deletion of PDC1,
as documented by slightly improved μmax and YS X
values for the strain VG3 (pdc1Δgdh1Δ). The decreased
fitness of the strains in which GDH1 was deleted, is due
to a reduced nitrogen assimilation rate [35]. In the
absence of GDH1, the GS-GOGAT system (coaction of
two enzymes, a glutamate synthase, GLT1, and a gluta-
mine synthetase, GLN1) [36,37] and the glutamate dehy-
drogenase, coded by GDH2 [38], are responsible for
ammonia assimilation. Both alternatives use NADH
instead of NADPH, thus explaining the high metabolic
adjustment predicted for the GDH1 in silico mutants
(Figure 2B and 2C). In comparison with Gdh1, lower
activity has been reported for both of the alternative sys-
tems. Consequently, overexpression of the enzymes
involved in the alternative pathways is a required step in
order to recover the cellular fitness [39]. We proceeded
experimentally with GDH2 overexpression as the use of
the GS-GOGAT system has the disadvantage of using
an important cellular resource - ATP.
The resulting strain VG4 (pdc1Δgdh1Δ ↑GDH2)
showed a significantly improved cellular fitness compared
to VG3 with μmax and YS X values similar to those
observed for VG2 and better than those obtained with
VG0. At these experimental conditions (batch cultiva-
tion), none of the introduced mutations seem to affect
ethanol production to any significant extent except that
the strains harbouring the GDH1 deletion tend to show a
slight increase in the substrate specific yield of ethanol.
Accumulation of several intermediates in the vanillin
pathway was observed following growth of all four dif-
ferent mutants. In combination, protocatechuic acid
Table 1 Physiological parameters for the reference and
metabolically engineered strains in batch cultivation
Strains Engineered Genotype μmax
a YS X
b YS EtOh
c YS gly
d
VG0 0.14 0.10 0.23 0.05
VG1 gdh1Δ 0.10 0.07 0.25 0.03
VG2 pdc1Δ 0.20 0.14 0.23 0.07
VG3 pdc1 Δgdh1Δ 0.11 0.10 0.27 0.05
VG4 pdc1 Δgdh1Δ ↑GDH2 0.17 0.17 0.25 0.07
aMaximum specific growth rate, h-1.
bOverall yield of biomass on substrate, gDW.gglc
-1.
cOverall yield of ethanol on substrate, geth.gglc
-1.
dOverall yield of glycerol on substrate, gGly.gglc
-1.
The biomass overall yield in glucose (YS X) was calculated based on all the
biomass obtained after glucose and ethanol consumption. Ethanol and
glycerol yields were calculated based on production only in the glucose
consumption phase.
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(PAC) and protocatechuic aldehyde (PAL) accounted for
more than 50% of the total products formed. Vanillin,
other intermediates and by-products such as vanillic
acid and vanillyl alcohol were found in very low
amounts and were not taken into account for further
analysis. The strain VG1 showed the lowest total yield
of compounds related to the vanillin biosynthetic path-
way (Figure 3), which might be related to the general
decreased fitness observed in this strain. The other three
engineered strains displayed better performance than
VG0 concerning VG production. Single deletion of
PDC1 in the strain VG2 resulted in an increase of 52%
in VG yield and a 30% increase in the overall yield of
the compounds from the de novo vanillin pathway.
Despite the adverse effect of the GDH1 deletion, double
deletion of PDC1 and GDH1 in VG3 resulted in 15%
increase in VG production compared to VG0. In con-
trast to strain VG0, the yield of VG increased by over
55% in the strain VG4. In all of the strains, increase in
VG was accompanied by accumulation of PAC and PAL
in different relative amounts (Figure 3). The most desir-
able distribution among these metabolites was observed
in the case of VG2, where 50% of the total products
formed was VG. Overall, the strain engineering carried
out during this study led us from a strain producing 9.8
mgVG/gglc to a strain producing 15.3 mgVG/gglc in batch
cultivation.
The extent to which VG production is affected by the
presence or absence of alcoholic fermentation is still
unknown. Above a critical threshold for glucose uptake
rate, co-existence of respiration and fermentation takes
place and the biomass yield is significantly lower due to
carbon channelling towards ethanol, known as the Crab-
tree effect [28]. This phenomenon, also termed overflow
metabolism, is typically observed in batch cultivation
where the initial glucose concentration is usually above
the critical threshold for mixed metabolism. In chemo-
stat cultivation, glucose concentration is kept at very
low levels and below the critical dilution rate (strain-
specific), the glucose uptake rate is low enough to
ensure exclusive respiratory metabolism [27,40,41].
Respiratory vs fermentative metabolism for VG production
In an attempt to test whether reduced fermentation
would lead to increased biomass and/or VG production,
the VG0 reference strain and the best performing
mutants in batch cultivations (VG2 and VG4) were
selected for further characterization in glucose-limited
chemostat cultures at a dilution rate of 0.1 h-1and 20 g/l
feed glucose concentration. VG2 showed increased fit-
ness as demonstrated by a higher biomass yield (YS X)
accompanied by slightly increased ethanol and a slightly
decreased glycerol yields, as compared to VG0 (Table
2). Under these conditions, VG2 shows 5.6 mgVG/gglc,
40% higher VG yield than VG0. In contrast, VG4 dis-
played a large decrease in YS X, while ethanol and gly-
cerol production were significantly increased (Table 2).,
At the same time, the VG production observed for this
strain remains very similar to that of the reference strain
(Table 2).
The strain VG0 showed a glucose uptake rate (rS) of
3.9 ± 0.2 mmolglcggw
-1.h-1, whereas VG2 has an uptake
rate of 3.5 ± 0.2 mmolglcggw
-1.h-1. The lower glucose
uptake decreases the overflow metabolism in the strain,
leading to decreased rates of ethanol, glycerol and acet-
ate formation. At the same time, VG2 exhibits a higher
conversion of PAC into the products of the later steps
in the vanillin pathway (Figure 4A). The strain VG4 dis-
plays a lower biomass yield on glucose and a
Figure 3 Vanillin b-D-glucoside yield observed for the reference strain (VG0) and metabolically engineered mutants (VG1-4) in batch
cultivations. Substrate overall yield for vanillin b-D-glucoside (YS VG, mgVG/gglc), protocatechuic acid (YS PAC, mgPAC/gglc) and protocatechuic
aldehyde (YS PAL, mgPAL/gglc) obtained for the reference and engineered strains in batch culture. Pie charts are presented to illustrate relative
distribution of PAC, PAL and VG for each strain.
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corresponding higher rS value suggesting an increased
overflow metabolism (Table 2). Accordingly, a signifi-
cantly increased production of ethanol (1.5-fold) and
glycerol (4-fold) was observed. Despite the severe impact
of the overflow metabolism on the biomass yield of the
VG4 strain in the conditions tested, better conversion of
PAC into downstream metabolites was observed, espe-
cially to PAL (Figure 4A). A possible interpretation of
this result is that the VG4 strain has higher availability
of NADPH, due to the engineered reduced demand for
this cofactor for ammonium metabolism. This most
likely affords a thermodynamically more favoured con-
version of PAC into PAL, as hypothesised during target
selection.
The predominantly respiro-fermentative metabolism
observed for all engineered strains (VG0, VG2 and VG4)
implies that the critical dilution rate (indicative of respira-
tory capacity) of the strains is very low. By gradually
decreasing the dilution rate in a glucose-limited chemo-
stat, we verified that the critical dilution rate for both
VG2 and VG0 was below 0.015. Such a low respiratory
capacity could be the result of combined effects of pro-
duct/by-products toxicity and due to the background of
the strain. Employing this experimental setup made it
possible to lower the ethanol production rate to 0.130
mmolethggw
-1.h-1 for VG0 and to 0.065 mmolethggw
-1.h-1
for VG2, while the rate of glucose uptake was 0.37 and
Figure 4 Vanillin b-D-glucoside yield observed for the reference strain (VG0) and metabolically engineered mutants (VG1-4) in
continuous cultivations. A - Biomass specific production rate (mgmetab.gdw
-1.h-1) for protocatechuic acid (PAC), protocatechuic aldehyde (PAL)
and VG in glucose limited chemostat cultivation at dilution rate of 0.1 h-1. B - Substrate specific yield (YS Metab, mgmetab/gglc) for PAC, PAL and
VG for strains VG0 and VG2 in glucose limited chemostat cultivation at different dilution rates - 0.1 h-1(Top) and 0.015 h-1(*, Bottom).
Table 2 Physiological parameters for the reference and
metabolically engineered strains in chemostat cultivation
at dilution rate 0.1 h-1
Strain VG0 VG2 VG4
Engineered Genotype pdc1Δ pdc1 Δgdh1Δ
↑GDH2
YS X (gDW.gglc
-1) 0.151 ± 0.008 0.159 ± 0.003 0.115 ± 0.005
YS eth (geth.gglc
-1) 0.283 ± 0.005 0.290 ± 0.008 0.32 ± 0.01
YS gly (mggly.gglc
-1) 3.4 ± 0.3 2.1 ± 0.4 11 ± 9
YS acet (mgacet.gglc
-1) 7.3 ± 0.3 7.6 ± 0.3 4 ± 2
YS PAC (mgPAC.gglc
-1) 27 ± 2 23.5 ± 0.3 15.5 ± 0.3
YS PAL (mgPAL.gglc
-1) 7 ± 2 9 ± 2 7.2 ± 0.2
YS VG (mgVG.gglc
-1) 4 ± 1 5.6 ± 1 4.16 ± 0.07
rs(mmolglc.gDW
-1.h-1) 3.9 ± 0.2 3.5 ± 0.3 4.8 ± 0.2
reth(mmoleth.gDW
-1.h-1) 4.3 ± 0.3 3.9 ± 0.3 6.1 ± 0.4
rgly(mmolgly.gDW
-1.h-1) 0.026 ± 0.003 0.014 ± 0.004 0.10 ± 0.08
racet(mmolacet.gDW
-1.h-1) 0.086 ± 0.006 0.079 ± 0.006 0.05 ± 0.003
rPAC(mmnolPAC.gDW
-1.h-1) 0.12 ± 0.01 0.10 ± 0.01 0.087 ± 0.03
rPAL(mmolPAL.gDW
-1.h-1) 0.036 ± 0.008 0.040 ± 0.007 0.045 ± 0.003
rVG(mmolVG.gDW
-1.h-1) 0.009 ± 0.003 0.011 ± 0.002 0.012 ± 0.001
Substrate yields for biomass (X), ethanol (eth), glycerol (Gly), atetate (Ace),
protocathechuic acid (PAC), protocathechuic adehyde (PAL) and vanillin b-D-
glucoside (VG) on glucose (glc) are represented by YS X (or metabolite). Specific
glucose uptake rate is represented by rS. Specific production rate for ethanol,
glycerol, acetate, PAC, PAL and VG are represented by rmetabolite.
Triplicates of all chemostats were performed.
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0.30 mmolglcggw
-1.h-1, respectively. With VG2, the VG
concentration in the broth was 500 mg/l, (32 mgVG/gglc),
a two-fold increase compared to that of VG0, which pro-
duced 250 mg/l (15 mgVG/gglc) (Figure 4B). These results
confirm that VG2 has better respiratory capacity than
that of the reference strain VG0 and that lowering the
overflow metabolism results in higher VG yield. The fact
that higher yields of the intermediates PAC and PAL as
well as of the final product, VG, are obtained at low dilu-
tion rates, suggests a significantly increased flux through
the vanillin biosynthetic pathway. In both strains, the
observed conversion of PAL into VG is more efficient at
low dilution rates. This confirms that low overflow meta-
bolism is linked to an increased precursor and/or cofac-
tors supply, enabling higher VG productivity.
Analysis of the experimental results
In an attempt to better understand the metabolic flux
changes at the whole network level and, therefore, the
basis for the observed improved VG production, the
flux phenotypes of VG0, VG2 and VG4 were simulated
by using FBA [17]. The experimental results obtained
from the chemostat cultures, i.e. glucose uptake rate
and biomass yield, ethanol, acetate, glycerol and CO2
production rates, were added as constraints to the meta-
bolic model. The bounds for the deleted genes were set
to zero, as in the case of GDH1 deletion in VG4. How-
ever the choice of constraints for the PDC1 deletion is
not straightforward, as deleting PDC1 does not mean
that pyruvate decarboxylase activity will be zero. To cir-
cumvent this issue, and to account for different glucose
uptake rates of the mutants, the upper bound for PDC
flux was identified in each condition. Subsequently, the
phenotypes were simulated with upper bound for PDC
constrained to 80% of the previously found upper
bound.
Flux variability analysis
The flux distributions obtained with FBA are guaranteed
to be optimal, but not necessarily unique due to the
existence of a large number of alternative routes. This
renders the transformation of the experimentally deter-
mined levels of the products obtained into intracellular
fluxes, a difficult task. Nevertheless, stoichiometric simu-
lations provide an estimate of the possible range of flux
values for every reaction in the network. Fluxes which
are unique will have the same maximum and minimum
possible values. The flux ranges of all reactions of VG2
and VG4 were calculated and compared with those of
VG0, resulting in different categories as illustrated in
Figure 5. The first category consists of those reactions
for which flux is infeasible at steady-state, i.e. blocked
reactions. Among the remaining reactions (~570), only
50 have unique flux values for the reference strain and
for the mutants (VG2 and VG4). Almost all of these
reactions belong to category a, i.e. with no change
between the VG0 reference strain and the tested
mutants. The chemostat experiments were carried out
at the same dilution rate for all the strains, and as a
consequence, the simulation of reactions directly
coupled to biomass biosynthesis all fall within this cate-
gory. Examples include reactions from lipid, nucleotide
and amino acid metabolism.
The categories b and c contain the majority of the
reactions (~70%) for the VG2 and VG4 strains, yet the
distribution among the two categories is not alike for
the two mutant strains. In the case of VG2, 226 reac-
tions exhibit a larger range than observed for the refer-
ence strain (category b) and a similar number of
reactions exhibit a smaller range than observed in the
VG0 (category c). For the VG4 strain, most of the reac-
tions fall in category b, as expected due to its higher
glucose uptake rate. The VG2 strain exhibits a decreased
glucose uptake rate and the same biomass formation
rate as compared with VG0. Nevertheless, several reac-
tions from the central carbon metabolism show an
increased flux range (category b). These reactions
mainly belong to the tricarboxylic acid (TCA) cycle, the
pentose phosphate pathway and gluconeogenesis,
reflecting that this strain has decreased overflow meta-
bolism and ethanol production. A more active respira-
tion in this strain is further confirmed by the in silico
predicted increased oxygen uptake rate. Even though
this reaction is found in category c (with decreased flux
range), its lower bound is higher in VG2 than in VG0.
The remaining reactions present flux variability ranges
with partial or no overlap between the reference strain
and the mutants. These reactions were grouped in cate-
gory d, where the mutant flux upper bound is higher
than the reference flux upper bound, and category e
where the mutant flux lower bound is lower than the
reference flux lower bound. Together, categories d and e
comprise the reactions with the clearest differences
between the mutants and the reference. These include
reactions related to product formation (e.g. biosynthesis
of S-adenosylmethionine - the methyl-group donor in
the vanillin pathway) and glucose uptake (which was
experimentally determined), as well as reactions from
the ammonia metabolism.
Despite the increased VG production, the VG2 strain
exhibits a decreased flux through the aromatic amino
acid biosynthesis pathway from which the vanillin pre-
cursor is derived. Likewise, this strain shows a reduced
total flux through the VG pathway. The same trend was
found for the VG4 strain, implying that the metabolic
network is being adjusted for increased PAL and VG
production at the expense of a reduction of the total
carbon flow into aromatic amino acids until the VG bio-
synthesis branch. In actual fact, the reaction after which
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the production is increased is the conversion from PAC
to PAL. This reaction uses NADPH and ATP, two of
the most highly connected metabolites and cofactors
that are competed for by growth requirement.
Metabolite-centric analysis
To systematically explore the usage of cofactors and
other metabolites in the engineered strains, the turnover
of these metabolites can be calculated by summing all
the fluxes which are producing (or consuming) them
[42]. As the unique values of all the fluxes are unknown
due to alternative optima inherent to FBA of metabolic
networks, the minimum metabolite turnover was calcu-
lated by solving a linear programming problem (LPP)
for the minimization of metabolite turnover (see materi-
als and methods for details). This LPP formulation guar-
antees to find the minimum turnover of a given
metabolite that ensures the observed phenotype. The
direction of optimization, i.e. minimization, not only
avoids the unbound cyclic fluxes around the metabolite
under question, but also confers with the biological
hypothesis of minimal resource allocation by the cell in
terms of enzyme expression. Minimum metabolite turn-
over denotes how much flux needs to pass through a
given metabolite, although the distribution of this flux
among possible reactions may not be unique in all
cases. Nevertheless, the turnover calculated in this way
provides a lower bound on the flux through a metabo-
lite that can be used in complementation with flux
variability analysis.
Besides NADPH and ATP, the minimum turnover of
some other relevant metabolites was also calculated
(Figure 6). The minimum turnover for PAC is lower in
the strains VG2 and VG4 than for VG0; while for PAL
and VG the opposite trend is verified, in agreement with
the flux variability analysis. An increase in the glucose
uptake rate will result in an increase in glycolysis and
pentose phosphate pathway, which is reflected in the
increased minimum turnover of pyruvate and erythrose-
4-phosphate in the VG4 strain. On the other hand, the
VG2 strain exhibits a decreased glucose uptake rate and
Figure 5 Flux variability analysis. Reactions were classified based on the comparison of their flux variability range between the reference VG0
and the mutants VG2 and VG4. A- The scheme on the left-hand side illustrates the flux variability ranges defining the six different categories
(Blocked and a to e). Flux variability range for the reference strain (VG0) is represented in gray, and the mutant in black. The distribution of VG2
and VG4 reactios among different categories are presented in the bar chart, yellow and red, respectively. B- The reactions from mutant VG2
belonging to categories b and c are further classified accordingly to their metabolic function.
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consequently less flux through glycolysis and pentose
phosphate pathway. The same trends apply to ATP,
implying that most ATP available in the cell is being
produced from glycolysis. NADPH, S-adenosylmethio-
nine and UDP-glucose minimum turnovers are
increased for both simulated phenotypes, reflecting the
increased flux through ACAR, hsOMT and UGT leading
to PAL and VG. The analysis above provides insight
into the intracellular flux changes and pinpoints meta-
bolites that play a role in the engineered strains.
Three VG overproducing strains were successfully
designed and constructed during this study. Systems
biology tools, such as the yeast genome-scale model,
were used throughout the study, from the strain design
to the analysis of the physiological data resulting from
the fermentation studies of the constructed mutants.
The in silico predicted increase in the product yield was
above 2-fold (Figure 2A). Indeed, 2-fold improvement in
the yield was observed for one of the mutants, albeit at
low dilution rate. On the other hand, the observed
improvement in batch cultivation was close to a 1.5-fold
increase. The limited kinetic and regulatory information,
as well as the lack of tools to integrate such information
within genome-scale metabolic models, are the main
likely reasons for the discrepancy between the predicted
and the experimentally determined yields. The need for
accounting of the regulatory information is even more
apparent when considering the fact that an isoenzyme
was chosen as a target. Effects of deletion of a gene cod-
ing for an isoenzyme on the flux re-routing are hard to
predict. In reality, quantitative prediction of flux distri-
butions following down-regulation or overexpression of
a gene (or corresponding enzyme activity) is still in its
infancy. Advances within this area would require more
experimental data on the regulation of metabolic net-
works as well as flux simulation tools that can integrate
such information. Regulation at both the hierarchical
and metabolic level is of particular relevance for vanillin
production as the shikimate pathway for aromatic
amino acids biosynthesis is tightly regulated in yeast
[43]. As an example, Luttik and co-workers were able to
increase the total flux through this pathway by 4.5-fold
Figure 6 Minimum turnover of selected metabolites from the central carbon metabolism and from the VG biosynthetic pathway
(including cofactors). Metabolites from the central carbon metabolism: glucose-6-phosphate, erythrose-4-phosphate, pyruvate and ethanol;
Metabolites from the VG biosynthetic pathway (ATP, NADPH, SAM and UDP-glucose). Metabolites for which minimum turnover was calculated
are represented by filled circles, metabolites for which no minimum turnover was calculated are represented by open rings. Reactions are
represented as arrows. Qualitative variation of the minimum turnovers relatively to the reference (VG0) is shown by the arrows next to each
metabolite; yellow corresponds to VG2 while red corresponds to VG4.
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in S. cerevisiae through alleviation of the DAHP
synthase feed-back inhibition mechanisms [44].
Conclusions and Future Perspectives
The in silico strategy design revealed the sensitivity of
the target predictions towards the reference flux distri-
bution used for simulating the mutants. To this end, it
was crucial to use basic physiological knowledge for
simulating different relevant yeast phenotypes. On the
experimental front, three yeast strains with improved
vanillin b-D-glucoside production were designed based
on a model-guided metabolic engineering strategy.
Physiological characterization of these mutants in che-
mostat cultivation (and subsequent in silico flux analy-
sis) allowed us to conclude that they display increased
cofactor availability for VG production. Further
increase of cofactor availability would be of great inter-
est in attempting to decrease the accumulation of
intermediates (especially PAC and PAL) and to favour
their conversion into VG. Subsequently, identification
and overexpression of an eventual rate limiting enzyme
from the vanillin biosynthetic pathway may serve to
enhance conversion of pathway intermediates into the
final product, VG. Furthermore, all the strains, includ-
ing the reference, were found to have poor respiratory
capacity and thereby high ethanol yield. Improving
respiratory capacity of the selected overproducers will
be an essential feature for future work. In fact, low
dilution rate continuous cultivation (concurrent with
better respiration) of an overproducer strain resulted
in notably high titer of vanillin b-D-glucoside - 500
mg/l, 5-fold higher than the 45 mg/l reported by Han-
sen and co-workers [5].
In summary, the framework presented in this study
comprises of i) in silico target prediction that accounts
for the available physiological information; ii) systematic
ranking of the targets based on the predicted metabolic
adjustments; iii) in vivo verification through genetic
engineering and fermentation; and iv) reaction/metabo-
lite centric analysis of the experimental results. Our
results demonstrate the applicability of in silico model-
ling tools for overproduction of a product from a multi-
step heterologous pathway in a eukaryotic system.
Materials and methods
Model simulations
Five new reactions were introduced in the Saccharo-
myces cerevisiae stoichiometric model [22] to convert 3-
dehydroshikimate, a natural intermediate in aromatic
amino acids biosynthesis, into vanillin b-D-glucoside
(VG). Furthermore all the intermediates in the pathway
were allowed to be secreted, based on the experimental
evidence. FBA simulations were performed using linear
programming library GLPK ftp://ftp.gnu.org/gnu/glpk/,
while MOMA simulations were performed using quad-
ratic programming library OOQP [45].
Strategy design to improve VG production in S. cerevi-
siae was performed by using OptGene with Biomass-
Product Coupled Yield (BPCY) as design objective func-
tion [16].
Minimization of metabolite turnover
Metabolite turnover or flux-sum is the sum of all
incoming or outgoing fluxes around a particular meta-
bolite under pseudo-steady state conditions [42,46]. Let
Fi denote metabolite turnover of metabolite i and its
mathematical definition is given by Φ i
k
ik kS v= ∑12 | | ,
where Sik represents the stoichiometric coefficient of
metabolite i in reaction k and vk is the flux of reaction
k. By calculating the sum of all absolute flux values
through (in and out) a given metabolite eliminates
further concern about reactions reversibility. Further-
more, given the steady state assumption, the metabolite
turnover will be half of the calculated sum.
Due to existence of alternative optimal FBA solutions
within genome-scale models, minimum of metabolite
turnover was calculated, given predetermined exchange
fluxes (including growth), using a linear programming
formulation as follows:
min
. .
(
Φ i
j
ij j
j j j j j j j
s t
S v
v for
∑ =
≤ ≤ ∈ ℜ ≤
0
     and and Flux capacity constraint s, including uptake and secretion reactions)
Plasmids and strains
The strain Saccharomyces cerevisiae VAN286 obtained
by Hansen et al. was used as the background strain in
this work. In order to produce vanillin, this strain must
be transformed with a plasmid containing the gene
EntD from Escherichia coli, coding for a PPTase. This
enzyme is indispensable for post-translational activation
by phosphopantetheinylation of ACAR in S. cerevisiae
[5]. All the strains constructed during this study
(Table 3) were transformed with the plasmid containing
EntD prior to cultivation in order to produce VG.
Cloning UGT72E2 in S. cerevisiae VAN286
The integrative plasmid pARB021 containing the gene
UGT72E2 from Arabidopsis thaliana coding for a
UDPG-glucosyltransferase was obtained by replacing the
URA3 marker by the HIS3 marker in plasmid pJH665
with the restriction enzyme XmaI. Restriction enzymes
and buffers from New England Biolabs were used and
the conditions for restriction followed manufacture
instructions. The HIS3 gene was PCR amplified using
the primers His3_Fw and His3_Rev (Additional file 1,
Table S1), the plasmid pWJ1213 [47] was used as
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template DNA and amplification was achieved using
Phusion™ Hot Start High-Fidelity DNA Polymerase
(Finnzymes Oy, Espoo, Finland). GFX™ PCR DNA and
Gel Band Purification Kit (GE Healthcare) were used for
DNA purifications and ligation was performed with T4
DNA ligase (New England Biolabs). The plasmid was
treated with Antarctic Phosphate (New England Biolabs)
in order to avoid recirculation. The ligation mixture was
deactivated and transformed into chemo-competent
DH5a E. coli cells. Ampicillin resistance was used as E.
coli selection marker and plasmid extraction was per-
formed using a GenElute HP Plamsid Miniprep Kit
(Sigma-Aldrich). The plasmid ARB021 was verified by
restriction analysis and sequencing of the PCR amplified
HIS3 marker with the primers MarkSeq_Fw and Mark-
Seq_Rev from Additional file 1, Table S1 (StarSEQ,
Mainz, Germany). The correct plasmid was then
restricted with SphI and transformed into the yeast TPI1
promoter locus of VAN286, thus creating the strain
VG0, producing VG from glucose. High efficiency yeast
transformation method was used to construct the yeast
strains [48].
Model guided strain construction
PDC1 and GDH1 gene deletions, as well as GDH2 over-
expression were achieved by gene targeting through
homologous recombination of bipartite PCR fragments,
using URA3 gene from Kluyveromyces lactis as a marker
[49]. The marker was flanked by direct repeats that
allowed restoring of uracil auxotrophy by plating the
cells in agar medium containing 5-Fluoroorotic acid
(5-FOA) after each genetic manipulation [50].
The primers used for amplifying the up and down-
stream regions flanking the PDC1 and GDH1 gene
(approximately 500 bp each) are listed in Additional file
1, Table S1, as well as the primers used to amplify K. lac-
tis URA3 flanked by direct repeats from the plasmid
pWJ1042 [51]. Strain VG1 was obtained by deleting the
gene GDH1 in the strain VG0. Strain VG2 was obtained
by deleting the gene PDC1 also in the strain VG0. Strain
VG3 was obtained by deleting gene GDH1 in the strain
VG2. The deletions were verified by analytical PCR using
the primers PDC1_Ver_FW and PDC1_Ver_REV for
PDC1 deletion, and GDH1_Ver_FW and GDH1_Ver_-
REV for GDH1 deletion (Additional file 1, Table S1).
Strain VG4 was obtained from VG3 by swapping the
native GDH2 promoter by the strong constitutive promo-
ter of the gene PGK1, as previously reported by Nissen et
al. [8]. A 500 bp fragment upstream the GDH2 open
reading frame (ORF) used for homologous recombination
was obtained from VG3 genomic DNA with the primers
GDH2(UP)_Fw and GDH2(UP)_Rev (Additional file 1,
Table S1). The downstream fragment used for homolo-
gous recombination was amplified from the plasmid
pPGK1-GDH2 [8] with the primers PGK1_GDH2(Dw)
_Fw and PGK1_GDH2(Dw)_Rev listed in Additional file
1, Table S1. 1479 bp of the PGK1 promoter region were
used to substitute the GDH2 original promoter, while the
initial 500 bp of the GDH2 OFR were used to ensure
accurate targeting. The promoter swapping was verified
by analytical PCR with the primers PGK1verif and
Gdh2verif (Additional file 1, Table S1), amplifying 420 bp
of the PGK1 promoter to 1300 bp of GDH2.
Medium Composition
A defined minimal medium as described by Verduyn et
al. (1992) with 20 g/l glucose as sole carbon source was
Table 3 Yeast strains and plasmids used in this study
Yeast Strain Relevant genotype Reference
VAN286 MATa his3D1 leu2D0 met15D0 ura3D0 adh6::LEU2 bgl1::KanMX4 PTPI1::3DSD [AurC]::HsOMT [NatMX]::ACAR
[HphMX]
Hansen et al. 2009 [5]
VG0 MATa his3D1 leu2D0 met15D0 ura3D0 adh6::LEU2 bgl1::KanMX4 PTPI1::3DSD [AurC]::HsOMT [NatMX]::ACAR
[HphMX]::UGT72E2 [HIS3]
This study
VG1 MATa his3D1 leu2D0 met15D0 ura3D0 adh6::LEU2 bgl1::KanMX4 PTPI1::3DSD [AurC]::HsOMT [NatMX]::ACAR
[HphMX]::UGT72E2 [HIS3] gdh1
This study
VG2 MATa his3D1 leu2D0 met15D0 ura3D0 adh6::LEU2 bgl1::KanMX4 PTPI1::3DSD [AurC]::HsOMT [NatMX]::ACAR
[HphMX]::UGT72E2 [HIS3] pdc1
This study
VG3 MATa his3D1 leu2D0 met15D0 ura3D0 adh6::LEU2 bgl1::KanMX4 PTPI1::3DSD [AurC]::HsOMT [NatMX]::ACAR
[HphMX]::UGT72E2 [HIS3] pdc1 gdh11
This study
VG4 MATa his3D1 leu2D0 met15D0 ura3D0 adh6::LEU2 bgl1::KanMX4 PTPI1::3DSD [AurC]::HsOMT [NatMX]::ACAR
[HphMX]::UGT72E2 [HIS3] pdc1 gdh1 GDH2::PPGK1-GDH2
This study
Plasmid Gene content Plasmid type Selection marker Reference
pJH589 EndD (E. coli) CEN-ARS (S. cerevisiae) URA3 Hansen et al. [5]
pJH665 UGT72E2 (Arabidopsis thaliana) CEN-ARS (S. cerevisiae) URA3 Hansen et al. [5]
pARB021 UGT72E2 (Arabidopsis thaliana) Integration (S. cerevisiae) HIS3 This work
pWJ1042 Recyclable URA3 (Kluyveromyces lactis) CEN-ARS (S. cerevisiae) Reid et al. [51]
pPGK1-GDH2 PPGK1-GDH2 (S. cerevisiae) Integration (S. cerevisiae) KanMX3 Nissen et al. [8]
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used for cell cultivation [52]. The medium composition
used for batch and continuous cultivation in well con-
trolled bioreactors was as follows: 5.0 g/l (NH4)2SO4,
3.0 g/l KH2PO4, 0.5 g/l Mg2SO4, 2.0 ml/l trace metal
solution, 1.0 ml/l vitamins solution, 0.05 ml/l antifoam
204 (Sigma-Aldrich A-8311) and 80 mg/l L-methionine.
Trace metal solution contained 3 g/L FeSO4.7H2O,
4.5 g/L ZnSO4.7H2O, 4.5 g/L CaCl2.6H2O, 0.84 g/L
MnCl2.2H2O, 0.3 g/L CoCl2.6H2O, 0.3 g/L
CuSO4.5H2O, 0.4 g/L NaMoO4.2H2O, 1 g/L H3BO3, 0.1
g/L KI and 15 g/L Na2EDTA.2H2O. Vitamins solution
included 50 mg/l d-biotin, 200 mg/l para-amino benzoic
acid, 1.0 g/l nicotinic acid, 1.0 g/l Ca-pantothenate, 1.0
g/l pyridoxine HCL, 1.0 g/l thiamine HCl and 25 mg/l
m-inositol.
The pH was adjusted to 5 by addition of 2N NaOH
prior to autoclavation, the glucose was autoclaved sepa-
rately and methionine and vitamins solutions were sterile
filtered (0.2 μm pore-size Ministart®-Plus Sartorius AG,
Geottingen, Germany) and added after autoclavation.
Batch cultivations
Batch cultivations were executed in well-controlled,
aerobic, 2.2 B Braun Biotech Biostat B fermentation sys-
tems with a working volume of 2 L (Sartorius AG, Geot-
tingen, Germany). Proper mixing conditions were
ensured by two disk-turbine impellers rotating at 800
RPM and 4 baffles. The pH was automatically controlled
at 5 by addition of 2N NaOH. The temperature was
kept constant at 30°C. The air flow rate was 1 vvm
(volume air per volume of broth per minute).
Prior to inoculation, 100 ml precultures were culti-
vated in 500 ml baffled shake-flasks at 30°C until OD600
nm 5 in an orbital shaker (150 RPM). Minimal medium
as described above was used to grow the precultures
with 20 g/l glucose. The bioreactors were inoculated to
an initial OD600 nm ranging from 0.5 to 0.7.
Continuous cultivations
Aerobic, carbon limited continuous cultivations were
carried out in 2.2 B Braun Biotech Biostat B fermenta-
tion systems (as described above for batch cultivations)
with a constant working volume of 1.5 L. The tempera-
ture was kept at 30°C, the pH was maintained at 5 by
addition of 2N NaOH, the stirring speed was 600 RPM
and the air flow was 1 vvm. Minimal medium with 20
g/l glucose was used to feed the bioreactors at a con-
stant dilution rate of 0.1 h-1. The volume was kept con-
stant at 1.5 l by controlling the level of broth inside the
vessel. Steady state conditions were assumed after at
least 5 residence times and CO2 and biomass concentra-
tions were constant.
Off-gas analysis
For both cultivation modes (batch and continuous), off-
gas passed through a condenser to minimize evaporation
loss during the fermentation and filter sterilized before
carbon dioxide and oxygen were quantified in a Brüel &
Kjær 1308 acoustic gas analyser (Brüel & Kjær, Nærum,
Denmark).
Biomass determination
Samples were maintained at 4°C post sampling and the
biomass concentration was monitored by optical density
at 600 nm (OD600 nm) and dry cell weight. OD600 nm
was measured throughout all the fermentation in a Shi-
madzu UV mini 1240 spectrophotometer (Shimadzu
Europe GmbH, Duidberg, Germany). The samples were
diluted with distilled water in order to obtain measure-
ments in the linear range of 0 to 0.6 OD600 nm. Dry cell
weight was determined by filtering a known volume of
fermentation broth with pre-dried 0.45 μm pore-size
nitrocellulose filters (Sartorius AG, Geottingen, Ger-
many), which were subsequently washed with a 3× sam-
ple volume 0.9% NaCl saline solution. The filters were
then dried for 20 minutes at 150 W in a microwave
oven and kept in a desiccator while cooling for at least
2 h. The filters where finally weighted using an analyti-
cal balance.
Glucose and external metabolites analysis
The fermentation samples were immediately filtered
using a 0.45 μm pore-size syringe-filter (Sartorius AG,
Geottingen, Germany) and stored at -20°C until further
analysis. Glucose, ethanol, glycerol, pyruvate, succinate
and acetate were determined by high performance liquid
chromatography (HPLC) analysis using an Aminex
HPX-87H ion-exclusion column (Bio-Rad Laboratories,
Hercules, CA). The column temperature was kept at 60°
C and the elution was performed using 5 mM H2SO4
with flow rate of 0.6 ml/min. Metabolites detection was
performed by a RI-101 differential refractometer detec-
tor (Shodex) and an UVD340U absorbance detector
(Dionex) set at 210 nm.
Extracellular vanillin, vanillin b-D-glucoside (VG), pro-
tocatechuic acid (PAC), protocatechuic aldehyde (PAL)
and vanillic acid were quantified by high performance
liquid chromatography (HPLC) using Agilent 1100 series
equipment with a Luna C18 column (Phenomenex). A
gradient of methanol (+ 1% tetra-fluoroacetic acid) and
water (+ 1% tetra-fluoroacetic acid) at a flow rate of 0.3
ml/min was used as mobile phase. The column was kept
at 300 bar and 30°C. Metabolite detection was per-
formed using a UV diode-array detector set at 280 and
310 nm.
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Additional material
Additional File 1: Table S1: List of primers used in this study.
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